Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Wout W. A. van den Broek"'
Autor:
Jaouad Azzahhafi MD, Wout W. A. van den Broek MD, Dean R. P. P. Chan Pin Yin MD, Ankie M. Harmsze PharmD, PhD, Ron H. N. van Schaik MSc, PhD, Jurriën M. ten Berg MD, PhD
Publikováno v:
Journal of Cardiovascular Pharmacology and Therapeutics, Vol 28 (2023)
Background Guidelines recommend prasugrel or ticagrelor for acute coronary syndrome (ACS) patients. However, these P2Y 12 inhibitors increase bleeding risk compared to clopidogrel. Although genotype-guided P2Y 12 -inhibitor selection has been shown t
Externí odkaz:
https://doaj.org/article/5a149674c1a946d4b3d076bf10c2f034
Autor:
Jaouad Azzahhafi, Thomas O. Bergmeijer, Wout W. A. van den Broek, Dean R. P. P. Chan Pin Yin, Senna Rayhi, Joyce Peper, Willem L. Bor, Daniel M. F. Claassens, Ron H. N. van Schaik, Jurriën M. ten Berg
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Aims: To determine the clinical efficacy, adverse events and side-effect dyspnea of CYP3A4*22 and CYP3A5 expressor status in ticagrelor treated patients.Methods and results: Ticagrelor treated patients from the POPular Genetics randomized controlled
Externí odkaz:
https://doaj.org/article/7ac9d46665ce483189d6a3185410c1aa
Autor:
Anne G. Raafs, Andrea Boscutti, Michiel T. H. M. Henkens, Wout W. A. van den Broek, Job A. J. Verdonschot, Jerremy Weerts, Davide Stolfo, Vincenzo Nuzzi, Paolo Manca, Mark R. Hazebroek, Christian Knackstedt, Marco Merlo, Stephane R. B. Heymans, Gianfranco Sinagra
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 6 (2022)
Background Speckle tracking echocardiographic global longitudinal strain (GLS) predicts outcome in patients with new onset heart failure. Still, its incremental value on top of left ventricular ejection fraction (LVEF) in patients with nonischemic, n
Externí odkaz:
https://doaj.org/article/41cf2c74ee1c446f935ead66325c9b6a
Autor:
Asim Cengiz Akbulut, Ryanne A. Arisz, Constance C. F. M. J. Baaten, Gaukhar Baidildinova, Aarazo Barakzie, Rupert Bauersachs, Jur ten Berg, Wout W. A. van den Broek, H. C. de Boer, Amandine Bonifay, Vanessa Bröker, Richard J. Buka, Hugo ten Cate, Arina J. ten Cate-Hoek, S. Cointe, Ciro De Luca, Ilaria De Simone, Rocio Vacik Diaz, Françoise Dignat-George, Kathleen Freson, Giulia Gazzaniga, Eric C. M. van Gorp, Anxhela Habibi, Yvonne M. C. Henskens, Aaron F. J. Iding, Abdullah Khan, Gijsje H. Koenderink, Akhil Konkoth, Romaric Lacroix, Trisha Lahiri, Wilbur Lam, Rachel E. Lamerton, Roberto Lorusso, Qi Luo, Coen Maas, Owen J. T. McCarty, Paola E. J. van der Meijden, Joost C. M. Meijers, Adarsh K. Mohapatra, Neta Nevo, Alejandro Pallares Robles, Philippe Poncelet, Christoph Reinhardt, Wolfram Ruf, Ronald Saraswat, Claudia Schönichen, Roger Schutgens, Paolo Simioni, Stefano Spada, Henri M. H. Spronk, Karlygash Tazhibayeva, Jecko Thachil, L. Vallier, Alicia Veninga, Peter Verhamme, Chantal Visser, Steve P. Watson, Philip Wenzel, Ruth A. L. Willems, Anne Willers, Pengyu Zhang, Konstantinos Zifkos, Anton Jan van Zonneveld
Publikováno v:
Thrombosis and Haemostasis. Georg Thieme Verlag
Thrombosis and haemostasis. Schattauer GmbH
Thrombosis and haemostasis. Schattauer GmbH
The Fourth Maastricht Consensus Conference on Thrombosis included the following themes. Theme 1: The “coagulome” as a critical driver of cardiovascular disease. Blood coagulation proteins also play divergent roles in biology and pathophysiology,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd95dbe34ad6519ebc8bd48af7de3f1d
https://cris.maastrichtuniversity.nl/en/publications/24c748a9-e928-4dca-9834-d6c9dad4cd6a
https://cris.maastrichtuniversity.nl/en/publications/24c748a9-e928-4dca-9834-d6c9dad4cd6a
Publikováno v:
American Journal of Cardiovascular Drugs. Adis International Ltd
BackgroundThe cytochrome P450 (CYP) 2C9 enzyme plays a role in the metabolization of clopidogrel. Carriage of a CYP2C9 loss-of-function (LoF) allele has been associated with attenuated pharmacokinetics, leading to a diminished pharmacodynamic respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc171445154cd51c1a48fb3069617c5b
https://cris.maastrichtuniversity.nl/en/publications/e8f5ef3a-e315-4341-816b-2607179c8632
https://cris.maastrichtuniversity.nl/en/publications/e8f5ef3a-e315-4341-816b-2607179c8632
Publikováno v:
Pharmacogenomics, 22(12), 727-730. Future Medicine Ltd.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f495a9b63479346ae768f01dd7ba2406
https://doi.org/10.2217/pgs-2021-0078
https://doi.org/10.2217/pgs-2021-0078
Autor:
Michael J, Nugteren, Gert J, de Borst, Wout W A, van den Broek, Jur M, Ten Berg, L Jaap, Kappelle, Çağdaş, Ünlü
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 166
The population of elderly with cardiovascular diseases and multimorbidity is rapidly growing. For decades, different antithrombotic therapies have been studied to find the most effective therapy in reducing the risk of cardiovascular events. Recently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c2180a4434f47d400d770b6fcef4c5a7
https://pubmed.ncbi.nlm.nih.gov/35736355
https://pubmed.ncbi.nlm.nih.gov/35736355
Publikováno v:
European Heart Journal, 43(43), 4599-4600. Oxford University Press
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abc2a0bfd283816668f08e5f18d24180
https://pubmed.ncbi.nlm.nih.gov/35678582
https://pubmed.ncbi.nlm.nih.gov/35678582